Literature DB >> 22343151

Increased intestinal permeability and Parkinson disease patients: chicken or egg?

D Salat-Foix1, K Tran, R Ranawaya, J Meddings, O Suchowersky.   

Abstract

UNLABELLED: Gastrointestinal involvement is a frequent and early event in the course of Parkinson Disease (PD), and may have a prominent role in the early pathophysiology of the disease. On the other hand, derangement in intestinal permeability could also result from the involvement of the gastrointestinal tract over the course of the disease. PATIENTS AND METHODS: The intestinal permeability of 12 non-selected PD patients was studied using a validated, non-invasive test; these results were compared to predefined age-adjusted reference values.
RESULTS: 4/12 PD patients had abnormal gastrointestinal permeability; two had both an abnormal lactulose/mannitol ratio and an abnormal sucrose concentration, and two an isolated abnormal result. An increased lactulose/mannitol ratio is consistent with defect of either the enterocytes or the tight junctions between them.
CONCLUSION: Intestinal permeability is increased in a significant proportion of unselected PD patients with minimal gastrointestinal symptoms. The significance of this finding needs to be further evaluated.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22343151     DOI: 10.1017/s0317167100013202

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  24 in total

Review 1.  Nutritional modulation of the intestinal microbiota; future opportunities for the prevention and treatment of neuroimmune and neuroinflammatory disease.

Authors:  Vincent C Lombardi; Kenny L De Meirleir; Krishnamurthy Subramanian; Sam M Nourani; Ruben K Dagda; Shannon L Delaney; András Palotás
Journal:  J Nutr Biochem       Date:  2018-04-19       Impact factor: 6.048

Review 2.  Is Gut Dysbiosis an Epicenter of Parkinson's Disease?

Authors:  Charul Rajput; Alika Sarkar; Nidhi Sachan; Neeraj Rawat; Mahendra Pratap Singh
Journal:  Neurochem Res       Date:  2021-01-05       Impact factor: 3.996

3.  Role of Dopamine and D2 Dopamine Receptor in the Pathogenesis of Inflammatory Bowel Disease.

Authors:  Ganna Tolstanova; Xiaoming Deng; Amrita Ahluwalia; Brankica Paunovic; Alona Prysiazhniuk; Lyudmyla Ostapchenko; Andrzej Tarnawski; Zsuzsanna Sandor; Sandor Szabo
Journal:  Dig Dis Sci       Date:  2015-05-14       Impact factor: 3.199

Review 4.  Enteric nervous system manifestations of neurodegenerative disease.

Authors:  Alcmène Chalazonitis; Meenakshi Rao
Journal:  Brain Res       Date:  2018-01-31       Impact factor: 3.252

Review 5.  Impaired tissue barriers as potential therapeutic targets for Parkinson's disease and amyotrophic lateral sclerosis.

Authors:  Xin Fang
Journal:  Metab Brain Dis       Date:  2018-04-22       Impact factor: 3.584

Review 6.  Intestinal permeability defects: is it time to treat?

Authors:  Matthew A Odenwald; Jerrold R Turner
Journal:  Clin Gastroenterol Hepatol       Date:  2013-07-12       Impact factor: 11.382

Review 7.  Parkinson's disease: Are gut microbes involved?

Authors:  Yogesh Bhattarai; Purna C Kashyap
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-09-02       Impact factor: 4.052

Review 8.  Nutritional habits, risk, and progression of Parkinson disease.

Authors:  Roberto Erro; Francesco Brigo; Stefano Tamburin; Mauro Zamboni; Angelo Antonini; Michele Tinazzi
Journal:  J Neurol       Date:  2017-10-10       Impact factor: 4.849

9.  Structural alterations of the intestinal epithelial barrier in Parkinson's disease.

Authors:  Thomas Clairembault; Laurène Leclair-Visonneau; Emmanuel Coron; Arnaud Bourreille; Séverine Le Dily; Fabienne Vavasseur; Marie-Françoise Heymann; Michel Neunlist; Pascal Derkinderen
Journal:  Acta Neuropathol Commun       Date:  2015-03-10       Impact factor: 7.801

10.  Distinct pattern of enteric phospho-alpha-synuclein aggregates and gene expression profiles in patients with Parkinson's disease.

Authors:  Martina Barrenschee; Dimitri Zorenkov; Martina Böttner; Christina Lange; François Cossais; Amelie Bernadette Scharf; Günther Deuschl; Susanne A Schneider; Mark Ellrichmann; Annette Fritscher-Ravens; Thilo Wedel
Journal:  Acta Neuropathol Commun       Date:  2017-01-05       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.